1. Home
  2. OCGN vs CLMB Comparison

OCGN vs CLMB Comparison

Compare OCGN & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.35

Market Cap

474.8M

Sector

Health Care

ML Signal

HOLD

Logo Climb Global Solutions Inc.

CLMB

Climb Global Solutions Inc.

HOLD

Current Price

$27.97

Market Cap

527.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCGN
CLMB
Founded
2013
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
474.8M
527.7M
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
OCGN
CLMB
Price
$1.35
$27.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$9.75
$80.00
AVG Volume (30 Days)
3.2M
118.0K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
0.60%
EPS Growth
N/A
14.29
EPS
N/A
0.48
Revenue
N/A
$652,517,000.00
Revenue This Year
N/A
$7.82
Revenue Next Year
$1,718.38
$5.83
P/E Ratio
N/A
$60.77
Revenue Growth
N/A
40.14
52 Week Low
$1.09
$15.25
52 Week High
$2.73
$145.00

Technical Indicators

Market Signals
Indicator
OCGN
CLMB
Relative Strength Index (RSI) 48.94 51.39
Support Level $1.29 $26.50
Resistance Level $1.49 $29.10
Average True Range (ATR) 0.06 1.09
MACD -0.00 -0.09
Stochastic Oscillator 28.57 49.65

Price Performance

Historical Comparison
OCGN
CLMB

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, United Kingdom, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

Share on Social Networks: